Literature DB >> 21796864

Seroprevalence of hepatitis B virus markers in individuals for physical examination in West China Hospital, China.

Y B Wang1, E Q Chen, Y L Cui, L Zeng, Y J Wang, H Tang.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) is the major cause of chronic hepatitis,cirrhosis, and hepatocellular carcinoma. The global epidemiological scenario of HBV infection has been changing rapidly over the last two decades due to an effective immunization programme initiated by the World Health Organization. The objective of this study is to estimate the prevalence of HBV in apparently adult people who were taken health examination in our Hospital.
METHODS: A cross-sectional seroprevalence analysis of hepatitis B virus infection was performed in 12037 adult residents (aged > or =18 years) in Chengdu, who visited Health Examination Center of West China Hospital of Sichuan University for routine medical check-up during the period from March to December 2008. A structured medical form was used to collect data on demographic characteristics and risk factors. ELISA was used to test sera for HBV markers. Descriptive and logistic regression models were used for analysis.
RESULTS: A total of 12,037 urban residents were involved. Prevalence of positive HBsAg was 6.1%, lower than the level of national seroepidemiological survey in (7.18%). Among HBsAg negative people, anti-HBs and anti-HBc was 60.2% and 13.6% respectively. There was a maximum between 18 to 29 years of age (61.8%) in anti-HBs positive people. Multivariate conditional logistic regressive analysis showed that, except for blood and vertical transmission, factors of male gender (OR, 1.876; 95% CI, 1.519-2.316; P < 0.001) and alcohol intake (OR, 0.689; 95% CI, 0.571-0.832; P < 0.001) were associated with a higher risk of positive HBsAg.
CONCLUSIONS: Among the medical examination people in Chengdu, HBsAg positive rate was lower than the national general population, the epidemiological characteristics of hepatitis B has been changed, because of vacination policies to the newborn; therefore, the necessity to continue to carry on the vaccination program.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796864

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  The seroprevalence of both hepatitis B and hepatitis C at the first-step health organizations and the difference between the urban and rural areas.

Authors:  Fatma Kalem; Şerife Yüksekkaya; Metin Başaranoğlu
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

2.  Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.

Authors:  Zu-Sen Wang; Wei-Dong Guo; Li-Qun Wu; Xin Yi; Chao Geng; Yu-Jun Li; Ru-Yong Yao
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

3.  Prevalence and factors associated with hepatitis B virus infection among senior citizens in a southern brazilian city.

Authors:  Danúbia Felippe Grassi de Paula Machado; Tatiana Martins; Daisson José Trevisol; Roger Augusto Vieira E Silva; Janaína Luz Narciso-Schiavon; Fabiana Schuelter Trevisol; Leonardo de Lucca Schiavon
Journal:  Hepat Mon       Date:  2013-04-30       Impact factor: 0.660

4.  Evaluation of the impact of hepatitis B vaccination in adults in Jiangsu province, China.

Authors:  Liguo Zhu; Xiangjun Zhai; Yefei Zhu; Weiguo Xu; Changjun Bao; Hong Peng; Qian Bian; Haitao Yang; Hua Wang; Zhibin Hu; Hongbing Shen
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

5.  Dosimetric comparison of intensity modulated and volumetric arc radiation therapy for gastric cancer.

Authors:  Zhiping Li; Jianshuang Zeng; Zi Wang; Hong Zhu; Yuquan Wei
Journal:  Oncol Lett       Date:  2014-07-18       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.